Combination Chemotherapy of Schistosomiasis in Laboratory Studies and Clinical Trials

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Antimicrobial Agents and Chemotherapy

• Publication date

  2003-05-01

• Fields of study

  Biology, Medicine, Environmental Science

• Identifiers
  DOI 10.1128/AAC.47.5.1487-1495.2003PMID 12709312PMCID PMC153321
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Randomized, double-blind, placebo-controlled trial of oral artemether for the prevention of patent Schistosoma haematobium infections.

  2003cited by this paper
• The global epidemiological situation of schistosomiasis and new approaches to control and research.

  2002influential reference
• Potential long-term toxicity of repeated orally administered doses of artemether in rats.

  2002cited by this paper
• The evolution of drug-resistant malaria: the role of drug elimination half-life.

  2002cited by this paper
• Recent investigations of artemether, a novel agent for the prevention of schistosomiasis japonica, mansoni and haematobia.

  2002influential reference
• Prevention and control of schistosomiasis and soil-transmitted helminthiasis.

  2002cited by this paper
• Interpreting low praziquantel cure rates of Schistosoma mansoni infections in Senegal.

  2002cited by this paper
• New malaria drug candidate could cure in a single dose.

  2002cited by this paper
• Comparative study of the effects of artemether and artesunate on juvenile and adult Schistosoma mansoni in experimentally infected mice.

  2002cited by this paper
• Association between Schistosoma mansoni and hookworm infections among schoolchildren in Côte d'Ivoire.

  2002cited by this paper
• Interaction between Grapefruit Juice and Praziquantel in Humans

  2002cited by this paper
• Schistosomiasis.

  2002cited by this paper
• Combination therapy for malaria: the way forward?

  2002cited by this paper
• Schistosomiasis: from risk assessment to control.

  2002cited by this paper
• The potential of artemether for the control of schistosomiasis.

  2001influential reference
• Praziquantel-induced tegumental damage in vitro is diminished in schistosomes derived from praziquantel-resistant infections

  2001cited by this paper
• Replacing oxamniquine by praziquantel against Schistosoma mansoni infection in a rural community from the sugar-cane zone of Northeast Brazil: an epidemiological follow-up.

  2001cited by this paper
• Are poor responses to praziquantel for the treatment of Schistosoma mansoni infections in Senegal due to resistance? An overview of the evidence

  2001cited by this paper
• Artesunate and praziquantel for the treatment of Schistosoma haematobium infections: a double-blind, randomized, placebo-controlled study.

  2001influential reference
• Effect of combined treatment with praziquantel and artemether on Schistosoma japonicum and Schistosoma mansoni in experimentally infected animals.

  2001cited by this paper
• Medical Helminthology in the 21st Century

  2001cited by this paper
• Current progress in the development and use of artemether for chemoprophylaxis of major human schistosome parasites.

  2001cited by this paper
• Schistosoma haematobium.

  2001cited by this paper
• Relative contribution of day-to-day and intra-specimen variation in faecal egg counts of Schistosoma mansoni before and after treatment with praziquantel

  2001cited by this paper
• Artemether administered together with haemin damages schistosomes in vitro.

  2001influential reference
• Artemether, an effective new agent for chemoprophylaxis against shistosomiasis in China: its in vivo effect on the biochemical metabolism of the Asian schistosome.

  2000cited by this paper
• Preventive effect of artemether in experimental animals infected with Schistosoma mansoni.

  2000cited by this paper
• Praziquantel: is there real resistance and are there alternatives?

  2000influential reference
• Behavioral and neural toxicity of the artemisinin antimalarial, arteether, but not artesunate and artelinate, in rats.

  2000cited by this paper
• Oral artemether for prevention of Schistosoma mansoni infection: randomised controlled trial.

  2000cited by this paper
• Experimental trials of an artemisinin derivative in treatment of Schistosoma mansoni infected mice.

  2000cited by this paper
• Bioavailability of Praziquantel Increases with Concomitant Administration of Food

  2000cited by this paper
• What is the effect of combining artesunate and praziquantel in the treatment of Schistosoma mansoni infections?

  2000influential reference
• The global status of schistosomiasis and its control.

  2000cited by this paper
• Praziquantel and the control of schistosomiasis.

  2000cited by this paper
• Effect of a Combination of the New Antischistosomal Drug Ro 15-5458 and Praziquantel on Different Strains of Schistosoma mansoni Infected Mice

  2000cited by this paper
• Efficacy of praziquantel against Schistosoma mansoni with particular consideration for intensity of infection

  2000influential reference
• Effect of praziquantel together with artemether on Schistosoma japonicum parasites of different ages in rabbits.

  2000cited by this paper
• The prophylactic effects of artemether against Schistosoma japonicum infections.

  2000cited by this paper
• Artemisinin drugs in the treatment of malaria: from medicinal herb to registered medication.

  1999cited by this paper
• Adverse effects in patients with acute falciparum malaria treated with artemisinin derivatives.

  1999cited by this paper
• The contribution of host-related factors to low cure rates of praziquantel for the treatment of Schistosoma mansoni in Senegal.

  1999cited by this paper
• Therapeutic and Operational Profiles of Metrifonate and Praziquantel in Schistosoma haematobium Infection

  1999cited by this paper
• Averting a malaria disaster.

  1999cited by this paper
• Antimalarial drug resistance and combination chemotherapy.

  1999cited by this paper
• Resistance to praziquantel: direct evidence from Schistosoma mansoni isolated from Egyptian villagers.

  1999cited by this paper
• Is Schistosomicidal Chemotherapy Sub-curative? Implications for Drug Resistance.

  1998cited by this paper
• Studies on schistosomiasis in western Kenya: II. Efficacy of praziquantel for treatment of schistosomiasis in persons coinfected with human immunodeficiency virus-1.

  1998cited by this paper
• Schistosomiasis control in Brazil.

  1998cited by this paper
• Single dose pharmacokinetics of oral artemether in healthy Malaysian volunteers.

  1997cited by this paper
• Day-to-day egg count fluctuation in Schistosoma mansoni infection and its operational implications.

  1996cited by this paper
• Experimental studies on early treatment of schistosomal infection with artemether.

  1995cited by this paper
• Experimental studies on early treatment of schistosomal infection with artemether.

  1995cited by this paper
• Antischistosomal drugs: past, present ... and future?

  1995cited by this paper
• Drug-resistant schistosomiasis: resistance to praziquantel and oxamniquine induced in Schistosoma mansoni in mice is drug specific.

  1994cited by this paper
• [Effect of arteether on Schistosoma japonicum].

  1992cited by this paper
• Oxamniquine pharmacokinetics in healthy Kenyan African volunteers.

  1991cited by this paper
• Pharmacokinetics of praziquantel in healthy volunteers and patients with schistosomiasis.

  1990cited by this paper
• In vitro and in vivo studies of the effect of artemether on Schistosoma mansoni

  1989cited by this paper
• Effect of combined low dose praziquantel and oxamniquine on different stages of schistosome maturity.

  1989cited by this paper
• Anti-schistosome chemotherapy enhanced by antibodies specific for a parasite esterase.

  1988cited by this paper
• Susceptibility of Schistosoma japonicum to different developmental stages to praziquantel.

  1987cited by this paper
• Oxamniquine pharmacokinetics in hepatosplenic schistosomiasis in the Sudan.

  1987cited by this paper
• Susceptibility of Schistosoma japonicum to different developmental stages to praziquantel.

  1987cited by this paper
• A review of clinical experience with oxamniquine.

  1987cited by this paper
• The chemotherapeutic effect of praziquantel against Schistosoma mansoni is dependent on host antibody response.

  1987cited by this paper
• Dosage trial of a combination of oxamniquine and praziquantel in the treatment of schistosomiasis in Zimbabwean schoolchildren.

  1986cited by this paper
• Schistosoma mansoni: chemotherapy of infections of different ages.

  1986cited by this paper
• Increased exposure of parasite antigens at the surface of adult male Schistosoma mansoni exposed to praziquantel in vitro

  1986cited by this paper
• Praziquantel: mechanisms of anti-schistosomal activity.

  1985cited by this paper
• Praziquantel.

  1984cited by this paper
• The profile of the trematodicidal compound praziquantel.

  1984cited by this paper
• Synergy of concurrent low dose oxamniquine and praziquantel in schistosomiasis.

  1983cited by this paper
• [Chemotherapeutic effect of artesunate in experimental schistosomiasis].

  1983cited by this paper
• The treatment of experimental schistosomiasis with a combination of oxamniquine and praziquantel.

  1983cited by this paper
• Chemotherapeutic effect of artesunate in experimental schistosomiasis

  1983cited by this paper
• STUDIES ON THE EFFICACY OF ARTEMETHER IN EXPERIMENTAL SCHISTOSOMIASIS

  1982cited by this paper
• [Studies on the efficacy of artemether in experimental schistosomiasis (author's transl)].

  1982cited by this paper
• [Studies on the efficacy of artemether in experimental schistosomiasis (author's transl)].

  1982cited by this paper
• In vivo and in vitro experiments on the effects of praziquantel on Schistosoma mansoni. A light and electron microscopic study.

  1981cited by this paper
• A summary of the efficacy of praziquantel against schistosomes in animal experiments and notes on its mode of action.

  1981cited by this paper
• Current results in the clinical therapy of schistosomiasis mansoni.

  1980cited by this paper
• Multicentre trials of praziquantel in human schistosomiasis: design and techniques.

  1979cited by this paper
• The development of Schistosoma haematobium in the hamster.

  1978cited by this paper
• A comparison of the susceptibility to praziquantel of Schistosoma haematobium, S. japonicum, S. mansoni, S. intercalatum and S. mattheei in hamsters

  1977influential reference
• Experimental chemotherapy of schistosomiasis mansoni

  1977cited by this paper
• Praziquantel, a new broad-spectrum antischistosomal agent

  1977cited by this paper
• The efficacy of praziquantel against cestodes in animals

  1977cited by this paper
• Synthesis and properties of praziquantel, a novel broad spectrum anthelmintic with excellent activity against Schistosomes and Cestodes

  1977cited by this paper
• The susceptibility to praziquantel of Schistosoma haematobium in the baboon (Papio anubis) and of S. japonicum in the vervet monkey (Cercopithecus aethiops)

  1977cited by this paper
• Culture of Schistosoma haematobium in vivo and in vitro.

  1976cited by this paper
• The control of immature Schistosoma mansoni in mice by UK 3883, a novel 2-aminomethyltetrahydroquinoline derivative.

  1971cited by this paper
• A New Series of 2-Aminomethyltetrahydroquinoline Derivatives displaying Schistosomicidal Activity in Rodents and Primates

  1969cited by this paper
• Experimental chemotherapy of Schistosomiasis mansoni.

  1968cited by this paper
• IN VITRO CULTIVATION OF SCHISTOSOMA MANSONI.

  1965cited by this paper

• Impact of nanostructured formulations for schistosomiasis treatment: a systematic review of in vivo preclinical evidence.

  2025cites this paper
• Identifying hotspots of S. haematobium infection following praziquantel treatment during multiple annual mass drug administration campaigns in Zimbabwe

  2025cites this paper
• Schistosomicidal and immunomodulatory effects of Momordica charantia in Schistosoma mansoni-infected mice

  2025cites this paper
• Efficacy of a Single Oral Dose of Artesunate plus Sulfalene-Pyrimethamineversus Praziquantel in the Treatment of Schistosoma mansoni in Kenyan Children: An Open-Label, Randomized, Exploratory Trial.

  2024cites this paper
• Efficacy and safety of single-dose artesunate plus sulfalene/pyrimethamine combined with praziquantel for the treatment of children with Schistosoma mansoni or Schistosoma haematobium in western Kenya: a randomised, open-label controlled trial

  2024cites this paper
• Efficacy and safety of praziquantel plus artemisinin-based combinations versus praziquantel in the treatment of Kenyan children with Schistosoma mansoni infection: open-label, randomized, head-to-head, non-inferiority trial

  2024cites this paper
• Therapeutic and vaccinomic potential of moonlighting proteins for the discovery and design of drugs and vaccines against schistosomiasis.

  2024cites this paper
• Schistosomicidal Effects of Moringa oleifera Seed Oil Extract on Schistosoma mansoni‐Infected Mice

  2024cites this paper
• In Vitro and In Vivo Antischistosomal Activity Profiling and Pharmacokinetics of Ozonide Carboxylic Acids.

  2023cites this paper
• Bioactivity of Trigonella foenum (Fenugreek) oil on immunological and biochemical response of Schistosoma mansoni infected mice.

  2023cites this paper
• Recent findings regarding the synergistic effects of emodin and its analogs with other bioactive compounds: Insights into new mechanisms.

  2023cites this paper
• In Vitro Cercaricidal Activity, Acute Toxicity, and GC/MS Analysis of Some Selected Ghanaian Medicinal Plants

  2023cites this paper
• Oxamniquine Derivatives Overcome Praziquantel Treatment Limitations for Schistosomiasis

  2023cites this paper
• Plant-derived compounds for the treatment of schistosomiasis: Improving efficacy via nano-drug delivery

  2022cites this paper
• Juglone: "A novel immunomodulatory, antifibrotic, and schistosomicidal agent to ameliorate liver damage in murine schistosomiasis mansoni".

  2022cites this paper
• Schistosome Sulfotransferases: Mode of Action, Expression and Localization

  2022cites this paper
• Anti‐inflammatory, antioxidant, anti‐fibrotic and schistosomicidal properties of plumbagin in murine schistosomiasis

  2022cites this paper
• Optimal single sampling time-point for monitoring of praziquantel exposure in children

  2021cites this paper
• Algorithm for diagnosis of early Schistosoma haematobium using prodromal signs and symptoms in pre-school age children in an endemic district in Zimbabwe

  2021cites this paper
• REPURPOSING OF ANTI-MALARIAL SYNRIAM AND TESTING ITS EFFICACY AGAINST EGYPTIAN STRAIN OF SCHISTOSOMA HAEMATOBIUM By HEBAT-ALLAH

  2020cites this paper
• Drug metabolism and pharmacokinetics of praziquantel: A review of variable drug exposure during schistosomiasis treatment in human hosts and experimental models

  2020cites this paper
• REPURPOSING OF ANTI-MALARIAL SYNRIAMTM AND TESTING ITS EFFICACY AGAINST EGYPTIAN STRAIN OF SCHISTOSOMA HAEMATOBIUM

  2020cites this paper
• Efficacy and safety of praziquantel and dihydroartemisinin piperaquine combination for treatment and control of intestinal schistosomiasis: A randomized, non-inferiority clinical trial

  2020cites this paper
• THE EFFECT OF GENISTEIN AGAINST SCHISTOSOMA MANSONI IN EXPERIMENTALLY INFECTED MICE

  2020cites this paper
• Searching drugs for Chagas disease, leishmaniasis and schistosomiasis: a brief review.

  2020cites this paper
• Characterization of lead compounds targeting the selenoprotein thioredoxin glutathione reductase for treatment of schistosomiasis.

  2020cites this paper
• Bevacizumab as a potential anti‐angiogenic therapy in schistosomiasis: A double‐edged, but adjustable weapon

  2020cites this paper
• The immunomodulatory activity of Chenopodium ambrosioides reduces the parasite burden and hepatic granulomatous inflammation in Schistosoma mansoni-infection.

  2020cites this paper
• Cucurbita pepo Seed Oil Induces Microsatellite Instability and Tegumental Damage to Schistosoma mansoni Immature and Adult Worms In vitro

  2020cites this paper
• Combined chemotherapy manifest less severe immunopathology effects in helminth-protozoa comorbidity.

  2019cites this paper
• In vitro activity of usnic acid potassium salt against different developmental stages of Schistosoma mansoni: An ultrastructural study.

  2019cites this paper
• Retraction Note: The epidemiology and chemotherapeutic approaches to the control of urinary schistosomiasis in school-age children (SAC): a systematic review

  2019cites this paper
• PZQ Therapy: How Close are we in the Development of Effective Alternative Anti-schistosomal Drugs?

  2019cites this paper
• EFEITO ESQUISTOSSOMICIDA E IMUNOMODULADOR DE Dysphania ambrosioides (L.) MOSYAKIN & CLEMANTS NA INFECCÇÃO EXPERIMENTAL POR Schistosoma mansoni SAMBON, 1907.

  2019cites this paper
• ANTI-MALARIA AND ANTI-PYRETIC CHANGES IN ARTHEMETHER- LUMEFANTRINE THERAPY ON RESIDENTS OF NNEWI, NIGERIA

  2019cites this paper
• The epidemiology and chemotherapeutic approaches to the control of urinary schistosomiasis in school-age children (SAC): a systematic review

  2019cites this paper
• Screening of a PDE-focused library identifies imidazoles with in vitro and in vivo antischistosomal activity

  2019cites this paper
• Asian Schistosomiasis: Current Status and Prospects for Control Leading to Elimination

  2019cites this paper
• Effect of Crocus sativus aqueous extract (saffron) on Schistosoma mansoni worms in experimentally infected mice

  2019cites this paper
• Biotransformation of Praziquantel by Cunninghamella elegans, Umbelopsis ramanniana, and Yarrowia lipolytica Metabolism

  2019cites this paper
• Phthalimido-thiazole as privileged scaffold: activity against immature and adult worms of Schistosoma mansoni

  2018cites this paper
• Drug Repurposing for Schistosomiasis: Combinations of Drugs or Biomolecules

  2018influential citation
• Antischistosomal agents: state of art and perspectives.

  2018cites this paper
• Vulvovaginal Infections

  2018cites this paper
• Intestinal Schistosomiasis Caused by Schistosoma japonicum: A Literature Review

  2018cites this paper
• Predictions of novel Schistosoma mansoni - human protein interactions consistent with experimental data

  2018influential citation
• Targeting thioredoxin glutathione reductase as a potential antischistosomal drug target.

  2018cites this paper
• Neglected tropical diseases: progress towards addressing the chronic pandemic.

  2017cites this paper
• Utilizing the ultrasensitive Schistosoma up-converting phosphor lateral flow circulating anodic antigen (UCP-LF CAA) assay for sample pooling-strategies

  2017cites this paper
• Lysine Deacetylase Inhibitors in Parasites: Past, Present, and Future Perspectives.

  2017cites this paper
• Chemotherapy and Drug Resistance in Schistosomiasis and Other Trematode and Cestode Infections

  2017cites this paper
• Synthesis and biological evaluation of novel imidazolinic, thiazolinic derivatives and aminosugars

  2017cites this paper
• Antischistosomal and Immune Enhancing Potential of Azadirachta Indica and Ekebergia Capensis in Mice Infected with Schistosoma Mansoni

  2017cites this paper
• Synergistic effects of in vitro combinations of piplartine, epiisopiloturine and praziquantel against Schistosoma mansoni.

  2017cites this paper
• Predictions of Protein-Protein Interactions in Schistosoma Mansoni

  2017cites this paper
• Immunohistochemical Activities and Anti-Helmintic of Blue GreenAlgae in Schistosoma mansoni Infection in Albino Micey

  2017cites this paper
• The anthelminthic drug praziquantel is a selective agonist of the sensory transient receptor potential melastatin type 8 channel

  2017cites this paper
• Ultrastructural changes of Schistosoma mansoni worms associated with administration of its polyvalent vaccine

  2017cites this paper
• The Efficacy of Single-Dose versus Double-Dose Praziquantel Treatments on Schistosoma mansoni Infections: Its Implication on Undernutrition and Anaemia among Primary Schoolchildren in Two On-Shore Communities, Northwestern Tanzania

  2017cites this paper
• Recent Advances in the Synthesis of Antischistosomal Drugs and Agents.

  2017cites this paper
• Medicinal chemistry of antischistosomal drugs: Praziquantel and oxamniquine.

  2017cites this paper
• SAFETY AND EFFICACY OF ARTEMISININ AND ITS DERIVATIVES IN THE TREATMENT OF SEVERE P. FALCIPARUM MALARIA INFECTION: A REVIEW

  2016cites this paper
• Comparative parasitological and electron microscopic studies on the effects of Nitazoxanide and Praziquantel in Schistosoma mansoni-infected mice

  2016cites this paper
• Independent origins of loss-of-function mutations conferring oxamniquine resistance in a Brazilian schistosome population.

  2016cites this paper
• Neglected Tropical Diseases - Sub-Saharan Africa

  2016cites this paper
• Genome-wide miRNAs expression profiles of Schistosoma japonicum schistosomula in response to artesunate.

  2016cites this paper
• Ellagic acid reduces murine schistosomiasis mansoni immunopathology via up-regulation of IL-10 and down-modulation of pro-inflammatory cytokines production

  2016cites this paper
• Quantitative proteomic analyses of Schistosoma japonicum in response to artesunate.

  2015cites this paper
• Anthelmintic Activity In Vivo of Epiisopiloturine against Juvenile and Adult Worms of Schistosoma mansoni

  2015cites this paper
• Evidence-Based Preventive Healthcare in the CWB Family Support Homes: The Healthy Learners Pilot Program

  2015cites this paper
• Subcutaneous nodule on the scrotum

  2015cites this paper
• The development of new treatment options for echinococcosis

  2015cites this paper
• Praziquantel and Arachidonic Acid Combination — An Innovative Approach to the Treatment of Schistosomiasis

  2015cites this paper
• Changing Policy and Practice in the Control of Pediatric Schistosomiasis

  2015influential citation
• Evaluation of Echinostoma liei worm, metacercaria and redia antigens for schistosomiasis control.

  2015cites this paper
• Efficacy and Safety of Arachidonic Acid for Treatment of School-Age Children in Schistosoma mansoni High-Endemicity Regions

  2015cites this paper
• Potential role of mefloquine (antimalarial drug) and methanol extract of Chenopodium ambrosioides and Sesbania sesban in mice infected with Schistosoma mansoni

  2015cites this paper
• Drug-Induced Exposure of Schistosoma mansoni Antigens SmCD59a and SmKK7

  2015cites this paper
• Subkutaner Knoten am Skrotum

  2015cites this paper
• PZQ PLUS ARA FOR REMEDY OF CHILDREN SCHISTOSOMIASIS Efficacy and Safety of Arachidonic Acid for Treatment of School-Aged Children in Schistosoma mansoni High-Endemicity Regions

  2015cites this paper
• Molluscicidal and Synergicidal Activities of the Leaves of Four Niger Delta Mangrove Plants Against Schistosomiasis Vectors

  2015cites this paper
• Follow-up of treatment response in imported acute schistosomiasis.

  2014cites this paper
• An Artemisinin Derivative of Praziquantel as an Orally Active Antischistosomal Agent

  2014cites this paper
• Cheminformatics Models for Inhibitors of Schistosoma mansoni Thioredoxin Glutathione Reductase

  2014influential citation
• Present-day anthelmintics and perspectives on future new targets

  2014cites this paper
• Efficacy of praziquantel in the treatment of Schistosoma haematobium infection among school-age children in rural communities of Abeokuta, Nigeria

  2014cites this paper
• Mutual action of anticancer and antiparasitic drugs: are there any shared targets?

  2014cites this paper
• Drugs for treating urinary schistosomiasis

  2014cites this paper
• Anti-schistosomal activity of five plant extracts on Swiss white mice infected with Schistosoma mansoni

  2014cites this paper
• Novel antipathy for schistosomiasis-the most lethal ailment of the tropical region.

  2014cites this paper
• Anthelmintic activity in vitro and in vivo of Baccharis trimera (Less) DC against immature and adult worms of Schistosoma mansoni.

  2014cites this paper
• Tetraoxanes as antimalarials: harnessing the endoperoxide.

  2014cites this paper
• Efficacy and safety of arachidonic acid for treatment of Schistosoma mansoni-infected children in Menoufiya, Egypt.

  2014cites this paper
• The hepatoprotective activity of blue green algae in Schistosoma mansoni infected mice.

  2014cites this paper
• Parasitological, pathological and immunological effects of hesperidin treatment on murine schistosomiasis mansoni

  2014cites this paper
• Detectable urogenital schistosome DNA and cervical abnormalities 6 months after single‐dose praziquantel in women with Schistosoma haematobium infection

  2013cites this paper
• In vivo schistosomicidal activity of three novels 8-hydroxyquinoline derivatives against adult and immature worms of Schistosoma mansoni

  2013cites this paper
• Parasitological evaluation of Ro 15-9268, a 9-acridanone-hydrazone derivative against Schistosoma mansoni in mice, and observations on changes in serum enzyme levels

  2013cites this paper
• Drugs for treating Schistosoma mansoni infection.

  2013cites this paper
• 3-Oxoacyl-ACP Reductase from Schistosoma japonicum: Integrated In Silico-In Vitro Strategy for Discovering Antischistosomal Lead Compounds

  2013cites this paper